Evaluation of oocyte quality in Polycystic ovary syndrome patients undergoing ART cycles.
AMH
ART cycles
Oocyte Quality
PCOS
Journal
Fertility research and practice
ISSN: 2054-7099
Titre abrégé: Fertil Res Pract
Pays: England
ID NLM: 101671668
Informations de publication
Date de publication:
05 Jan 2021
05 Jan 2021
Historique:
received:
23
07
2020
accepted:
09
12
2020
entrez:
5
1
2021
pubmed:
6
1
2021
medline:
6
1
2021
Statut:
epublish
Résumé
To evaluate factors affecting oocyte/embryo quality in PolyCystic Ovary Syndrome (PCOS) patients undergoing Assisted Reproductive Technology (ART) cycles. This case-control retrospective study was performed on PCOS patients referred to the infertility department of Imam Khomeini Hospital in Ahvaz from October 2017 to September 2019. Demographic and reproductive characterizations including age, gender, abortion history and infertility type (primary and secondary infertility) were extracted from patient's records. TSH, AMH, LH, FSH, prolactin, lipid profile and blood glucose was measured. Biochemistry pregnancy was checked by determination of serum βHCG level and then, clinical pregnancy was confirmed by observing of pregnancy sac and fetal heart rate using Transvaginal USS. One-hundred thirty-five patients include 45 PCOS and 90 Non-PCOS patients with mean age of 31.93 ± 5.04 and 30.8 ± 5.38 (p = 0.24) were considered as case and control groups respectively. Retrieved oocyte numbers were significantly higher in PCOS patients (p = 0.024), but there was no significant difference in number of oocyte subtypes (MI, MII and GV) between two groups. The embryo numbers and its subtypes did not differ significantly in both groups. The clinical pregnancy rate was insignificantly lower in PCOS patients (p = 0.066) and there was a significant correlation between retrieved oocyte numbers with age(r= -0.2, p= 0.022) and AMH level (r = 0.433, p < 0.0001) respectively. Cholesterol level had shown a positive significant correlation with number of MI oocytes (r = 0.421, p = 0.026) and MII oocytes significantly affected by age (r= -0.250, p = 0.004) and AMH level (r = 0.480, p < 0.0001). Using Receiver operation characteristic (ROC) curve analysis, the cut-off value of total number of oocytes was > 10.5 with area under curve of 0.619±0.054(sensitivity 55.56% and specificity 69.66%) CONCLUSIONS: The results of this study showed that although the number of oocytes in PCOS patients was significantly higher than non-PCOS patients, the quality of oocytes was not statistically different. The number and quality of embryos were not significantly different in both groups. Our results indicated a significant relationship between the level of AMH and the number of retrieved oocytes and embryos. We found there is a significant correlation between cholesterol level and number of MI oocytes.
Sections du résumé
BACKGROUND
BACKGROUND
To evaluate factors affecting oocyte/embryo quality in PolyCystic Ovary Syndrome (PCOS) patients undergoing Assisted Reproductive Technology (ART) cycles.
METHODS
METHODS
This case-control retrospective study was performed on PCOS patients referred to the infertility department of Imam Khomeini Hospital in Ahvaz from October 2017 to September 2019. Demographic and reproductive characterizations including age, gender, abortion history and infertility type (primary and secondary infertility) were extracted from patient's records. TSH, AMH, LH, FSH, prolactin, lipid profile and blood glucose was measured. Biochemistry pregnancy was checked by determination of serum βHCG level and then, clinical pregnancy was confirmed by observing of pregnancy sac and fetal heart rate using Transvaginal USS.
RESULTS
RESULTS
One-hundred thirty-five patients include 45 PCOS and 90 Non-PCOS patients with mean age of 31.93 ± 5.04 and 30.8 ± 5.38 (p = 0.24) were considered as case and control groups respectively. Retrieved oocyte numbers were significantly higher in PCOS patients (p = 0.024), but there was no significant difference in number of oocyte subtypes (MI, MII and GV) between two groups. The embryo numbers and its subtypes did not differ significantly in both groups. The clinical pregnancy rate was insignificantly lower in PCOS patients (p = 0.066) and there was a significant correlation between retrieved oocyte numbers with age(r= -0.2, p= 0.022) and AMH level (r = 0.433, p < 0.0001) respectively. Cholesterol level had shown a positive significant correlation with number of MI oocytes (r = 0.421, p = 0.026) and MII oocytes significantly affected by age (r= -0.250, p = 0.004) and AMH level (r = 0.480, p < 0.0001). Using Receiver operation characteristic (ROC) curve analysis, the cut-off value of total number of oocytes was > 10.5 with area under curve of 0.619±0.054(sensitivity 55.56% and specificity 69.66%) CONCLUSIONS: The results of this study showed that although the number of oocytes in PCOS patients was significantly higher than non-PCOS patients, the quality of oocytes was not statistically different. The number and quality of embryos were not significantly different in both groups. Our results indicated a significant relationship between the level of AMH and the number of retrieved oocytes and embryos. We found there is a significant correlation between cholesterol level and number of MI oocytes.
Identifiants
pubmed: 33397466
doi: 10.1186/s40738-020-00094-z
pii: 10.1186/s40738-020-00094-z
pmc: PMC7784377
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2Références
Nat Rev Endocrinol. 2018 May;14(5):270-284
pubmed: 29569621
Gynecol Obstet Fertil. 2003 Apr;31(4):350-4
pubmed: 12821065
Clin Biochem. 2009 Feb;42(3):210-4
pubmed: 19028482
Fertil Steril. 2015 Jan;103(1):112-8
pubmed: 25450303
Medicine (Baltimore). 2020 Mar;99(13):e19665
pubmed: 32221094
J Assist Reprod Genet. 2016 Jul;33(7):849-54
pubmed: 27052832
Best Pract Res Clin Obstet Gynaecol. 2016 Nov;37:25-37
pubmed: 27118252
Mol Hum Reprod. 2008 Dec;14(12):673-8
pubmed: 18996952
Fertil Steril. 2012 Jun;97(6):1438-43
pubmed: 22440252
J Int Med Res. 2017 Jun;45(3):1138-1147
pubmed: 28449632
Hum Reprod. 2012 Aug;27 Suppl 1:i2-21
pubmed: 22811312
Hum Reprod. 1999 Feb;14(2):354-8
pubmed: 10099978
J Assist Reprod Genet. 2009 Nov-Dec;26(11-12):557-60
pubmed: 19921421
Arch Gynecol Obstet. 2008 Mar;277(3):239-44
pubmed: 17899140
J Clin Endocrinol Metab. 2006 Oct;91(10):3878-84
pubmed: 16882750
Horm Metab Res. 2020 Feb;52(2):104-108
pubmed: 31975364
J Med Biochem. 2018 Dec 01;37(4):448-455
pubmed: 30584404